×
About 253 results

ALLMedicine™ Achlorhydria Center

Research & Reviews  75 results

Applications of bio-predictive dissolution tools for the development of solid oral dosa...
https://doi.org/10.1080/03639045.2022.2098315
Drug Development and Industrial Pharmacy; Xu J, Zhang L et. al.

Jul 6th, 2022 - Development and optimization of orally administered drug products often require bio-predictive tools to help with informing formulation and manufacturing decisions. Reliable bio-predictive dissolution toolkits not only allow rational development o...

In vitro digestion mimicking conditions in young and elderly reveals marked differences...
https://doi.org/10.1016/j.foodres.2022.111215
Food Research International (Ottawa, Ont.); Wang C, Zhao F et. al.

Jun 29th, 2022 - We applied in vitro models of gastrointestinal (GI) digestion simulating the conditions of the GI tract of healthy adults and elderly individuals with achlorhydria (EA) to investigate differences in the digestibility of meat (chicken, beef and por...

Pernicious Anemia Differential Diagnoses
https://emedicine.medscape.com/article/204930-differential

May 16th, 2022 - Diagnostic Considerations By definition, pernicious anemia refers specifically to vitamin B12 deficiency resulting from a lack of production of intrinsic factor (IF) in the stomach. However, vitamin B12 absorption is a complex process, and other c...

Somatostatin
https://emedicine.medscape.com/article/2089466-overview

May 16th, 2022 - Reference Range Somatostatin is a polypeptide that is released in the gastrointestinal tract by delta cells and the hypothalamus. It functions as a key regulatory peptide that has many physiologic effects as an inhibitor for many other hormones, i...

Somatostatin
https://emedicine.medscape.com/article/2089466-print

May 16th, 2022 - Somatostatin is a polypeptide that is released in the gastrointestinal tract by delta cells and the hypothalamus. It functions as a key regulatory peptide that has many physiologic effects as an inhibitor for many other hormones, including gastrin...

see more →

Drugs  18 results see all →

Clinicaltrials.gov  3 results

Clinical Utility of Handheld Hydrogen Breathalyzer in Identification of Food Sensitivities (AIRE Study)
https://clinicaltrials.gov/ct2/show/NCT04309396

Mar 10th, 2022 - Small intestinal bacterial overgrowth (SIBO) is defined as a condition in which an abnormally high amount of coliform bacteria is present in the small bowel and results in premature anaerobic fermentation of carbohydrates before reaching the colon...

Iron Sucrose Versus Ferrous Bis-glycinate for Treatment of Iron Deficiency Anemia
https://clinicaltrials.gov/ct2/show/NCT03009578

Jul 3rd, 2018 - Iron deficiency may result from inadequate dietary intake, achlorhydria or excessive ingestion of proton pump inhibitors, parasitic infestations, chronic infections and repeated pregnancies. Iron supplementation of antenatal patients is a basic te...

Cobalamin Absorption From Fortified Food
https://clinicaltrials.gov/ct2/show/NCT01399164

Oct 22nd, 2013 - Cobalamin (vitamin B12) deficiency is highly prevalent in the US and worldwide. Deficiency is most common in the elderly, with an average prevalence ≈25% over age 60 y. About 40% of older persons with low serum cobalamin have food cobalamin malabs...

see more →

News  5 results

Zollinger-Ellison Syndrome: Not Your Average Peptic Ulcer Disease
https://www.mdedge.com/clinicianreviews/article/140787/gastroenterology/zollinger-ellison-syndrome-not-your-average-peptic
Lauren Bowen Tooker, PA-C, Kathy Dexter, MLS, MHA, MPA, PA-C

Jul 5th, 2017 - IN THIS ARTICLE Diagnostic criteria Pharmacologic management Patient education A more severe variant of peptic ulcer disease, Zollinger-Ellison syndrome (ZES) is a rare, chronic, and potentially life-threatening ulcerative disorder. Because the sy.

Proton-Pump Inhibitors and Risk for Fractures: Breaking Through the Confusion
https://www.medscape.com/viewarticle/722993

Jun 7th, 2010 - Hello. I am Dr. David Johnson, Professor of Medicine and Chief of Gastroenterology at Eastern Virginia Medical School of Norfolk, Virginia. New news: The FDA has mandated that proton pump inhibitors (PPIs) will now have product labeling that says ...

Gastritis Patient Needs Increased Thyroxine Dose
https://www.mdedge.com/endocrinology/article/52797/pituitary-thyroid-adrenal-disorders/gastritis-patient-needs-increased
Doug Brunk

Patients with multinodular goiter required a thyroxine dosage increase of 22%–34% if they had impaired secretion of stomach acids, results from a large controlled study demonstrated. The finding suggests that “normal gastric acid secretion is impo.

Deficits of Gastric Acid Secretion Impair Absorption of Thyroxine
https://www.mdedge.com/familymedicine/article/27783/endocrinology/deficits-gastric-acid-secretion-impair-absorption
Family Practice News; Doug Brunk

Patients with multinodular goiter required a thyroxine dosage increase of 22%–34% if they had impaired secretion of stomach acids, results from a large controlled study demonstrated. The finding suggests that “normal gastric acid secretion is impo.

see more →